ATE552011T1 - Kolorektal-karzinom-antigen - Google Patents

Kolorektal-karzinom-antigen

Info

Publication number
ATE552011T1
ATE552011T1 AT04790870T AT04790870T ATE552011T1 AT E552011 T1 ATE552011 T1 AT E552011T1 AT 04790870 T AT04790870 T AT 04790870T AT 04790870 T AT04790870 T AT 04790870T AT E552011 T1 ATE552011 T1 AT E552011T1
Authority
AT
Austria
Prior art keywords
colorectal carcinoma
carcinoma antigen
eliciting
coa
diagnostic
Prior art date
Application number
AT04790870T
Other languages
English (en)
Inventor
Paul Robbins
Steven Rosenberg
Cristina Maccalli
Original Assignee
Ist Superiore Sanita
Nat Inst Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita, Nat Inst Health filed Critical Ist Superiore Sanita
Application granted granted Critical
Publication of ATE552011T1 publication Critical patent/ATE552011T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/19—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/24—Antigen-presenting cells [APC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT04790870T 2003-10-15 2004-10-15 Kolorektal-karzinom-antigen ATE552011T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51204003P 2003-10-15 2003-10-15
PCT/EP2004/012087 WO2005039632A1 (en) 2003-10-15 2004-10-15 Colorectal cancer antigen

Publications (1)

Publication Number Publication Date
ATE552011T1 true ATE552011T1 (de) 2012-04-15

Family

ID=34520047

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04790870T ATE552011T1 (de) 2003-10-15 2004-10-15 Kolorektal-karzinom-antigen

Country Status (6)

Country Link
US (1) US20090311279A1 (de)
EP (1) EP1677820B1 (de)
JP (1) JP2007519612A (de)
AT (1) ATE552011T1 (de)
CA (1) CA2542686A1 (de)
WO (1) WO2005039632A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090033375A (ko) * 2006-06-30 2009-04-02 베일러 리서치 인스티튜트 Ｇｍ-ｃｓｆ 및 인터페론 알파의 사용에 의해 생성되고 열처리 및 사멸된 암 세포가 로딩된 수지상 세포
EP2472264B1 (de) * 2007-02-27 2015-11-25 SentoClone International AB Multiplex-nachweis von tumorzellen unter verwendung einer gruppe von extrazelluläre marker bindenden agenten
US20180133327A1 (en) * 2015-03-16 2018-05-17 Amal Therapeutics Sa Cell Penetrating Peptides and Complexes Comprising the Same
CA3010779A1 (en) 2016-03-16 2017-09-21 Amal Therapeutics Sa Combination of an immune checkpoint modulator and a complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for use in medicine
EP3515476B1 (de) 2016-09-21 2024-05-22 Amal Therapeutics SA Zellpenetrierendes-peptid (cpp), multiepitop und tlr-peptidagonist enthältende fusion zur behandlung von krebs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291430B1 (en) * 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
JP2003135075A (ja) * 2001-11-05 2003-05-13 Research Association For Biotechnology 新規な全長ｃＤＮＡ
EP1519741A2 (de) * 2001-12-07 2005-04-06 Incyte Genomics, Inc. Mit zellwachstum, -differenzierung und -tod assoziierte proteine

Also Published As

Publication number Publication date
JP2007519612A (ja) 2007-07-19
EP1677820A1 (de) 2006-07-12
CA2542686A1 (en) 2005-05-06
WO2005039632A1 (en) 2005-05-06
EP1677820B1 (de) 2012-04-04
WO2005039632B1 (en) 2005-08-18
US20090311279A1 (en) 2009-12-17

Similar Documents

Publication Publication Date Title
NO20026245L (no) Forbedring av antistoff-cytokinfusjonsproteinformidlede immunresponser vedkombinert behandling med immuncytokinopptakforbedrende midler
ATE538215T1 (de) Expressionsprofil von prostatakarzinom
TW200510454A (en) Conjugates comprising human IL-18 and substitution mutants thereof
CY1111591T1 (el) Υβριδικη εκφραση πρωτεϊνων των neisseria
CY1114855T1 (el) Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1
MXPA05008794A (es) Antigeno de glicoproteina sima135 expresado en celulas tumorales humanas metastasicas.
EP1572728A4 (de) Polymer-konjugate mit verringerterantigenität, herstellungsverfahren undverwendungen
AU302182S (en) Blower
DE60329287D1 (de) Boehmitteilchen und diese enthaltende polymermaterialien
DK1617861T3 (da) Human serumalbumin-fri stabiliserede interferon flydende formuleringer
EP1706423B8 (de) Therapeutische und diagnostische anti-hsp 70-antikörper
ATE552011T1 (de) Kolorektal-karzinom-antigen
WO2002075507A3 (en) Anti-bacterial vaccine compositions
EP1230932A3 (de) Verwendung von Antikörpern zur Vakzinierung gegen Krebs
AU2003302165A1 (en) Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof.
DE60218710D1 (de) Gen und protein mit bezug zu hepatozellulärem karzinom
ATE497506T1 (de) Sars-verwandte proteine
WO2009049966A3 (en) Methods and tools for prognosis of cancer in her2+ patients
ITRM20020306A0 (it) Esteri in posizione 20 di camptotecine.
BR0314139A (pt) Derivados de 1,4-pirazina substituìdos
FR2803599B1 (fr) Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications
WO2002076384A3 (en) Therapeutic compositions that alter the immune response
DE602004011061D1 (de) Erhöhte t-zell tumor-eindringung durch light- mutanten
WO2008009028A3 (en) Methods of determining the prognosis of an adenocarcinoma
DE69935323D1 (de) Moraxella catharralis proteine